Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh · Delayed Price · Currency is BDT

108.70

-2.40 (-2.16%)

At close: Jun 16, 2026

3.52% (1Y)

Market Cap	25.11B -6.2%
Revenue (ttm)	14.78B +27.7%
Net Income	1.24B +117.1%
EPS	5.36 +117.1%
Shares Out	231.00M
PE Ratio	20.29
Forward PE	n/a
Dividend	2.10 (1.89%)
Ex-Dividend Date	Nov 17, 2025

Volume	701,976
Open	n/a
Previous Close	111.10
Day's Range	107.80 - 112.00
52-Week Range	96.00 - 147.50
Beta	-0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestin... [Read more]

Industry Pharmaceutical Preparations

Founded 2001

Employees 4,771

Stock Exchange Dhaka Stock Exchange

Ticker Symbol BEACONPHAR

Full Company Profile

Financial Performance

In fiscal year 2025, Beacon Pharmaceuticals's revenue was 12.54 billion, an increase of 17.20% compared to the previous year's 10.70 billion. Earnings were 946.51 million, an increase of 81.67%.

Financial Statements